EA
INSM icon

Everpar Advisors’s Insmed INSM Stock Holding History

Everpar Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,503
Closed -$246K – 313
2026
Q1 		$246K Sell
1,503
-70
-4% -$10.8K 0.08% 246
2025
Q4 		$274K Buy
1,573
+120
+8% +$21.9K 0.1% 213
2025
Q3 		$209K Buy
+1,453
New +$178K 0.08% 264

Other funds holding INSM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MCM
McRae Capital Management Morristown, New Jersey $508M AUM 14.21% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Everpar Advisors's INSM Position: Q2 2026 in Review

Everpar Advisors sold out of Insmed (INSM) in Q2 2026, closing a stake of 1,503 shares — an estimated $246K sold.

Everpar Advisors first reported a position in INSM in Q3 2025 and held it in 3 quarters. The position peaked at $274K in Q4 2025. 63 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Everpar Advisors reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
  • Everpar Advisors sold 1,503 Insmed shares in Q2 2026, an estimated $246K.
  • Everpar Advisors first reported a position in Insmed in Q3 2025 and held it in 3 quarters.
  • Everpar Advisors's Insmed position peaked at $274K in Q4 2025.
  • 63 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Everpar Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.